Subscribe To
PSTV / Plus Therapeutics, Inc. (PSTV) CEO Marc Hedrick on Q4 2021 Results - Earnings Call Transcript
Content Topics
Plus
Therapeutics
Inc
PSTV
Marc
Hedrick
2021
Results
Therapeutics
pstv
Earnings
Transcript
Stock
PSTV News
By Seeking Alpha
October 31, 2023
Plus Therapeutics, Inc. (PSTV) Q3 2023 Earnings Call Transcript
Plus Therapeutics, Inc. (NASDAQ:PSTV ) Q3 2023 Earnings Conference Call October 31, 2023 5:00 PM ET Corporate Participants Marc Hedrick - President an more_horizontal
By GlobeNewsWire
September 11, 2023
Plus Therapeutics Receives $1.9 Million Advance Payment from CPRIT and Plans to Present at the CPRIT Innovations in Cancer Prevention and Research Conference
AUSTIN, Texas, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”), a clinical-stage pharmaceutical compa more_horizontal
By Seeking Alpha
August 14, 2023
Plus Therapeutics, Inc. (PSTV) Q2 2023 Earnings Call Transcript
Plus Therapeutics, Inc. (NASDAQ:PSTV ) Q2 2023 Earnings Conference Call August 14, 2023 5:00 PM ET Corporate Participants Marc Hedrick - President and more_horizontal
By GlobeNewsWire
August 8, 2023
Plus Therapeutics to Announce Second Quarter 2023 Financial Results and Host Conference Call on August 14, 2023
AUSTIN, Texas, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company more_horizontal
By GlobeNewsWire
August 3, 2023
Plus Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference
AUSTIN, Texas, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company more_horizontal
By GlobeNewsWire
May 25, 2023
Plus Therapeutics to Present at the 2023 Virtual June Investor Summit
AUSTIN, Texas, May 25, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”), a clinical-stage pharmaceutical company more_horizontal
By Seeking Alpha
April 20, 2023
Plus Therapeutics, Inc. (PSTV) Q1 2023 Earnings Call Transcript
Plus Therapeutics, Inc. (PSTV) Q1 2023 Earnings Call Transcript. more_horizontal
By Zacks Investment Research
April 20, 2023
Plus Therapeutics (PSTV) Reports Q1 Loss, Tops Revenue Estimates
Plus Therapeutics (PSTV) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.19 p more_horizontal